Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Better hearing device design tested in 20 users

NCT ID NCT06597747

Symptom relief Sponsor: Med-El Corporation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a new behind-the-ear audio processor (SONNET 3) is more satisfying for people who already use a cochlear implant. Twenty experienced users tried the new design and reported their satisfaction. The goal was to see if small design changes improve daily comfort and ease of use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

20 people

The number who actually took part.

Started

Dec 2024

Finished

Jul 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Implanted with a MED-EL cochlear implant in at least one ear * ≥ 12 months since activation of the MED-EL audio processor * Consistently using a SONNET (EAS) or SONNET 2 (EAS) Audio Processor * Ability to complete all study procedures * Participant and parental (if applicable) commitment to comply with all study procedures for the duration of the study Exclusion Criteria: * Evidence that hearing loss is retrocochlear in origin * Unable to provide reliable feedback during cochlear implant programming * Skin or scalp condition precluding use of the study device * Unrealistic participant or parent (if applicable) motivation or expectations * Participants without a stable fitting map at enrollment e.g., due to changes in hearing, global health status, etc.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hearing loss, sensorineural are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Hearing Loss, Sensorineural sensorineural hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hearing loss, sensorineural

Contacts and locations

Locations

  • University of North Carolina

    Chapel Hill, North Carolina, 27517, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.